Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Circulating extracellular vesicles in human cardiorenal syndrome promote renal injury in a kidney-on-chip system
Emeli Chatterjee, … , Ravi Shah, Saumya Das
Emeli Chatterjee, … , Ravi Shah, Saumya Das
Published September 14, 2023
Citation Information: JCI Insight. 2023;8(22):e165172. https://doi.org/10.1172/jci.insight.165172.
View: Text | PDF
Clinical Research and Public Health Cardiology Nephrology

Circulating extracellular vesicles in human cardiorenal syndrome promote renal injury in a kidney-on-chip system

  • Text
  • PDF
Abstract

BACKGROUND Cardiorenal syndrome (CRS) — renal injury during heart failure (HF) — is linked to high morbidity. Whether circulating extracellular vesicles (EVs) and their RNA cargo directly impact its pathogenesis remains unclear.METHODS We investigated the role of circulating EVs from patients with CRS on renal epithelial/endothelial cells using a microfluidic kidney-on-chip (KOC) model. The small RNA cargo of circulating EVs was regressed against serum creatinine to prioritize subsets of functionally relevant EV-miRNAs and their mRNA targets investigated using in silico pathway analysis, human genetics, and interrogation of expression in the KOC model and in renal tissue. The functional effects of EV-RNAs on kidney epithelial cells were experimentally validated.RESULTS Renal epithelial and endothelial cells in the KOC model exhibited uptake of EVs from patients with HF. HF-CRS EVs led to higher expression of renal injury markers (IL18, LCN2, HAVCR1) relative to non-CRS EVs. A total of 15 EV-miRNAs were associated with creatinine, targeting 1,143 gene targets specifying pathways relevant to renal injury, including TGF-β and AMPK signaling. We observed directionally consistent changes in the expression of TGF-β pathway members (BMP6, FST, TIMP3) in the KOC model exposed to CRS EVs, which were validated in epithelial cells treated with corresponding inhibitors and mimics of miRNAs. A similar trend was observed in renal tissue with kidney injury. Mendelian randomization suggested a role for FST in renal function.CONCLUSION Plasma EVs in patients with CRS elicit adverse transcriptional and phenotypic responses in a KOC model by regulating biologically relevant pathways, suggesting a role for EVs in CRS.TRIAL REGISTRATION ClinicalTrials.gov NCT03345446.FUNDING American Heart Association (AHA) (SFRN16SFRN31280008); National Heart, Lung, and Blood Institute (1R35HL150807-01); National Center for Advancing Translational Sciences (UH3 TR002878); and AHA (23CDA1045944)

Authors

Emeli Chatterjee, Rodosthenis S. Rodosthenous, Ville Kujala, Priyanka Gokulnath, Michail Spanos, Helge Immo Lehmann, Getulio Pereira de Oliveira, Mingjian Shi, Tyne W. Miller-Fleming, Guoping Li, Ionita Calin Ghiran, Katia Karalis, JoAnn Lindenfeld, Jonathan D. Mosley, Emily S. Lau, Jennifer E. Ho, Quanhu Sheng, Ravi Shah, Saumya Das

×

Figure 9

Concordant expression of the target of hsa-miR-21-5p in KOC.

Options: View larger image (or click on image) Download as PowerPoint
Concordant expression of the target of hsa-miR-21-5p in KOC.
(A) Box-and...
(A) Box-and-whisker plot showing significantly higher expression (reads per million) of hsa-miR-21-5p in EVs from HFpEFCRS group compared with the HFpEFNO CRS group. (B) SMAD7 mRNA was significantly downregulated in the KOC cells treated by EVs from HFpEFCRS group compared with Healthy Control group. GAPDH was used as internal loading control. Three independent chips (technical replicates) were prepared for each biological replicate (n = 3 for Healthy Control and HFpEFNO CRS; n = 4 for HFpEFCRS) of each experimental group (averaged for each data point). Box plots represent the first quartile, median, and third quartile, with whiskers indicating minimum and maximum values. Results were analyzed by unpaired t test for A and 1-way ANOVA with Tukey’s post hoc test for B and expressed as ±SEM of 3 independent experiments. *, P < 0.05 **, P < 0.01; ***, P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts